Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers...
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a...
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a...
PARIS — A lawyer representing the victim in a horrific mass rape case in France slammed the apparent lack of interest from male lawmakers at a hearing Thursday. Speaking to...
A military judge on Monday postponed the trial in Al Qaeda’s 2000 bombing of the U.S. Navy destroyer Cole until next year to give defense lawyers more time to prepare...
State prosecutors took their own case to trial on Monday against three former Memphis Police Department officers who fatally beat Tyre Nichols, aiming to secure a murder conviction after jurors...
Last week was a fruitful one for public health and medicine. While the European Parliament adopted a new law boosting the transparency of drug trials, pharmaceutical company Abbvie dropped its...
WASHINGTON (Reuters) – Meta CEO Mark Zuckerberg made a key confession at a U.S. antitrust trial on Tuesday, saying he bought Instagram because it had a “better” camera than the...
The antitrust trial against Meta Platforms Inc. continues Tuesday, after CEO Mark Zuckerberg took the stand on Monday in a case he had long sought to sidestep. The tech giant...
CTA Content